Page 38 - HP2017FIN4PRN.indd
P. 38

Dar Al Dawa







                             Dar Al Dawa is a MENA-wide leader in pharmaceutical and
                             consumer health products.  With a history of more than 40 years, we
                             are a trusted leader and competence center with a reputation for
                             exceptional quality.  As a fully integrated pharmaceutical company,
                             we have a long established customer-centered approach to
                             developing, producing, marketing and commercializing high-quality
                             affordable medicines and wellness consumer products in emerging
                             markets, with more than 900 people serving patients in more than
                             40 countries throughout Middle East, North Africa and Europe.


                             Dar Al Dawa possesses a high-performance business drive
                             combining unparalleled experience, comprehensive capabilities
                             across all management, development, production, technology,
                             marketing and commercial teams and business functions.
                             According to Jordan’s Drug owners association, Dar Al Dawa is
                             ranked first in 2013 considering the number of new drug registration
                             submissions.


                             At Dar Al Dawa, we have the drive to high performance and the
                             experience to deliver. Our strategy is to focus on core competencies
                             and then execute, with customer centric high-performance, at every
                             stage from medicine development to commercialization.  This has
                             successfully made us the second largest player in Jordan and a
                             partner of choice to many collaboration (alliances) and healthcare
                             partners within MENA.


                             We are focused on four core therapy areas – anti-infectives,
                             respiratory, musculoskeletal and increasingly on CNS and CVS–
                             where we can apply our expertise and resources more effectively by
                             taking advantage of the knowledge of our integrated teams.  Our
                             goal is to develop and commercialize our compounds and those of
                             our collaboration partners in selected markets where a company of
                             our size can compete successfully for targeted disease states.

                                                                                                                                                                                                                               www.hawkary.com
                                                                                                                                                                                                                               info@hawkary.com
                                                                                                                                                                                                                               00964 66 251 9685







               26
               26                Our Suppliers Portfolio - Hawkary Co.
   33   34   35   36   37   38   39   40   41   42